Skip to main content

Table 1 Respiratory function tests of the patient with times in reference to her admission

From: Suspected acute exacerbation of idiopathic pulmonary fibrosis associated with interferon alpha therapy for hepatitis C: case report

  9 months earlier 4 months earlier
FEV1 - L (% predicted) 2.26 (88) 2.13 (83)
FVC - L (% predicted) 3.60 (111) 3.38 (105)
FEV1/FVC (% predicted) 0.63 (79) 0.63 (80)
TLC – L (% predicted) 5.38 (106) 5.05 (100)
DLCO/VA - mL/min/mmHg/L (% predicted) 1.62 (35) 1.64 (35)
  1. FEV1, forced expiratory volume in one second; FVC, forced vital capacity; TLC, total lung capacity; DLCO, carbon monoxide diffusing capacity; VA, alveolar volume.